Page last updated: 2024-10-21

3-methoxytyramine and Bradykinesia

3-methoxytyramine has been researched along with Bradykinesia in 2 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Research Excerpts

ExcerptRelevanceReference
" Behavioral deficits at the end of the 14-day dosing regime and on day 28 (i."1.40Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates. ( Davydova, TV; Fomina, VG; Gruden, MA; Kudrin, VS; Morozova-Roche, LA; Narkevich, VB; Sewell, RD; Wang, C, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gruden, MA1
Davydova, TV1
Narkevich, VB1
Fomina, VG1
Wang, C1
Kudrin, VS1
Morozova-Roche, LA1
Sewell, RD1
Abe, K1
Taguchi, K1
Wasai, T1
Ren, J1
Utsunomiya, I1
Shinohara, T1
Miyatake, T1
Sano, T1

Other Studies

2 other studies available for 3-methoxytyramine and Bradykinesia

ArticleYear
Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates.
    Behavioural brain research, 2014, Apr-15, Volume: 263

    Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Intranasal; alpha-Synuclein; Amyloid; Animals; Corpu

2014
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Brain research bulletin, 2001, Sep-01, Volume: 56, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Do

2001